SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Share News (IMM)

Share Price Information for Immupharma (IMM)

Share Price is delayed by 15 minutes
Get Live Data
4.40    -0.41 (-8.52%)
Bid:
4.40
Ask:
4.50
Spread: 0.10 (2.273%)
Market Cap: £27.45m
IMM Live PriceLast checked at - London Stock Exchange

Intraday Immupharma Share Chart

Immupharma News

LONDON MARKET OPEN: Europe opens higher ahead of construction PMI data
6 Aug 2025

LONDON MARKET OPEN: Europe opens higher ahead of construction PMI data

(Alliance News) - European blue-chips opened in the green on Wednesday, after US stocks retreated on Tuesday ahead of US President Donald Trump's tari...

Immupharma annual loss narrows as focused on clinical assets
19 May 2025

Immupharma annual loss narrows as focused on clinical assets

(Alliance News) - ImmuPharma PLC on Monday said its core anti-infective programme with antifungal and antibacterial candidates is progressing through ...

ImmuPharma celebrates "significant milestone" for P140 platform
13 Mar 2025

ImmuPharma celebrates "significant milestone" for P140 platform

(Alliance News) - ImmuPharma PLC on Thursday announced "new discoveries" regarding the mechanism of action of its P140 autoimmune technology platform.

AIM WINNERS & LOSERS: Hornby plots AIM exit; Ethernity deal progresses
13 Mar 2025

AIM WINNERS & LOSERS: Hornby plots AIM exit; Ethernity deal progresses

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday.

IN BRIEF: ImmuPharma notes share price surge after novel findings
28 Jan 2025

IN BRIEF: ImmuPharma notes share price surge after novel findings

ImmuPharma PLC - London-based specialist drug discovery and development company - Notes recent movements in its share price, as it has more than multi...

ImmuPharma can't explain near-400% stock jump
28 Jan 2025

ImmuPharma can't explain near-400% stock jump

(Sharecast News) - Specialist drug discovery and development outfit ImmuPharma has said that it can't pinpoint a reason behind its share price more th...

IN BRIEF: ImmuPharma shares climb on breakthrough autoimmune findings
9 Jan 2025

IN BRIEF: ImmuPharma shares climb on breakthrough autoimmune findings

ImmuPharma PLC - London-based specialist drug discovery and development company - Says its preclinical research program focused on P140 and the pathog...

AIM WINNERS & LOSERS: ImmuPharma jumps; Impax Asset hit by outflows
9 Jan 2025

AIM WINNERS & LOSERS: ImmuPharma jumps; Impax Asset hit by outflows

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday.